Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$305.85 4.85 (1.61%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 179.13(B)
Last Volume: 4,488,573 Avg Vol: 2,725,052
52 Week Range: $214.27 - $324.56
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  499
Guru Rank Value     : 3
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 2,117 4,213 23,771 31,503
Total Sell Value $662,802 $1,235,078 $6,471,520 $8,438,219
Total People Sold 1 1 3 6
Total Sell Transactions 1 2 4 8
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 2195
  Page 2 of 88  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Khosla Rachna SVP, Business Development   •       •      –    2024-05-02 4 D $277.37 $20,525 D/D (74) 8,068     -
   Busch Matthew C. VP, Finance & CAO   •       •      –    2024-05-02 4 D $277.37 $7,489 D/D (27) 4,626     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2024-05-02 4 D $277.37 $636,287 D/D (2,294) 659,501     -
   Griffith Peter H. EVP & CFO   •       •      –    2024-05-02 4 D $277.37 $189,166 D/D (682) 33,425     -
   Gordon Murdo EVP, Global Commercial Ops   •       •      –    2024-05-02 4 D $277.37 $210,246 D/D (758) 49,810     -
   Santos Esteban EVP, Operations   •       •      –    2024-05-02 4 D $277.37 $168,086 D/D (606) 68,924     -
   Reese David M EVP & Chief Technology Officer   •       •      –    2024-05-02 4 D $277.37 $180,291 D/D (650) 59,326     -
   Miller Derek SVP, Human Resources   •       •      –    2024-05-02 4 D $277.37 $42,160 D/D (152) 8,196     -
   Grygiel Nancy A. SVP & CCO   •       •      –    2024-05-02 4 D $277.37 $31,620 D/D (114) 12,000     -
   Graham Jonathan P EVP & Gen. Counsel & Secy.   •       •      –    2024-05-02 4 D $277.37 $163,926 D/D (591) 32,955     -
   Khosla Rachna SVP, Business Development   •       •      –    2024-04-30 4 D $276.38 $13,266 D/D (48) 8,142     -
   Miller Derek SVP, Human Resources   •       •      –    2024-04-30 4 D $276.38 $19,623 D/D (71) 8,348     -
   Graham Jonathan P EVP & Gen. Counsel & Secy.   •       •      –    2024-04-30 4 D $276.38 $189,597 D/D (686) 33,546     -
   Grygiel Nancy A. SVP & CCO   •       •      –    2024-04-30 4 D $276.38 $29,296 D/D (106) 12,114     -
   Gordon Murdo EVP, Global Commercial Ops   •       •      –    2024-04-30 4 D $276.38 $208,114 D/D (753) 50,568     -
   Reese David M EVP & Chief Technology Officer   •       •      –    2024-04-30 4 D $276.38 $190,702 D/D (690) 59,976     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2024-04-30 4 D $276.38 $630,699 D/D (2,282) 661,795     -
   Santos Esteban EVP, Operations   •       •      –    2024-04-30 4 D $276.38 $188,768 D/D (683) 69,530     -
   Griffith Peter H. EVP & CFO   •       •      –    2024-04-30 4 D $276.38 $166,657 D/D (603) 34,107     -
   Busch Matthew C. VP, Finance & CAO   •       •      –    2024-04-30 4 D $276.38 $4,698 D/D (17) 4,653     -
   Khosla Rachna SVP, Business Development   •       •      –    2024-03-18 4 D $268.87 $117,765 D/D (438) 8,190     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2024-03-18 4 D $268.87 $5,527,967 D/D (20,560) 664,077     -
   Griffith Peter H. EVP & CFO   •       •      –    2024-03-18 4 D $268.87 $1,389,520 D/D (5,168) 34,710     -
   Gordon Murdo EVP, Global Commercial Ops   •       •      –    2024-03-18 4 D $268.87 $1,737,169 D/D (6,461) 51,321     -
   Reese David M EVP & Chief Technology Officer   •       •      –    2024-03-18 4 D $268.87 $1,667,532 D/D (6,202) 60,666     -
  2195 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 88
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us